Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing
Go back to Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing| CACI INTERNATIONAL CLA (NASDAQ: CAI) | Delayed: 15.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.38 | 52 Week High | $11.53 | |||
| Open | $15.38 | 52 Week Low | $4.83 | |||
| Day High | $15.38 | P/E | 5.21 | |||
| Day Low | $15.38 | EPS | $2.95 | |||
| Volume | 93 | |||||
